Mesa Laboratories (MLAB) Financials: History & Chart

Mesa Laboratories, Inc.(MLAB)

Medical - Specialties · Lakewood, CO

$138.47-3.76 (-2.65%)

Delayed quote: Oct 6, 2026, 11:49 AM EDT

About Mesa Laboratories, Inc.

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Lakewood, CO

717 employees

www.mesalabs.com

Healthcare / Medical - Specialties

Sector: Healthcare
Industry: Medical - Specialties
CEO: Siddhartha C. Kadia

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	249.72M	60.14M	63.72M	65.13M	60.74M	59.54M	62.13M	62.84M	57.83M
Cost of Goods Sold	84.94M	21.13M	17.07M	23.33M	23.41M	27.05M	23.72M	23.09M	22.38M
Gross Profit	164.79M	39.01M	46.65M	41.80M	37.33M	32.49M	38.41M	39.75M	35.45M
Gross Profit Margin	66.0%	64.9%	73.2%	64.2%	61.5%	54.6%	61.8%	63.3%	61.3%
Total Operating Expenses	142.31M	31.98M	43.90M	33.82M	32.61M	29.43M	36.94M	33.98M	31.95M
Research & Development	20.05M	4.72M	5.25M	5.03M	5.05M	4.98M	5.10M	5.05M	4.63M
Selling, General & Administrative	107.94M	17.38M	34.21M	28.79M	27.56M	28.89M	31.85M	28.92M	27.31M
Operating Income (EBIT)	22.48M	7.03M	2.75M	7.97M	4.72M	3.06M	1.47M	5.78M	3.51M
Operating Margin	9.0%	11.7%	4.3%	12.2%	7.8%	5.1%	2.4%	9.2%	6.1%
Income Before Tax (EBT)	9.36M	4.35M	-1.59M	4.60M	2.00M	7.01M	461K	-2.22M	3.81M
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	10.86M	2.36M	2.60M	3.04M	2.86M	2.20M	2.52M	2.84M	3.02M
Other Income/Expense	-13.12M	-2.68M	-4.34M	-3.38M	-2.73M	3.95M	-1.01M	-8.00M	304K
Net Income	4.80M	2.83M	-4.14M	3.63M	2.48M	4.74M	-7.11M	-1.68M	3.43M
Income Tax Expense	4.55M	1.52M	2.54M	966K	-477K	2.27M	7.58M	-541K	384K
Net Profit Margin	1.9%	4.7%	-6.5%	5.6%	4.1%	8.0%	-11.4%	-2.7%	5.9%
EBITDA	45.44M	12.68M	8.50M	13.69M	10.57M	9.02M	8.97M	11.28M	9.58M
EBITDA Margin	18.2%	21.1%	13.3%	21.0%	17.4%	15.2%	14.4%	17.9%	16.6%
Depreciation & Amortization	22.96M	5.64M	5.75M	5.71M	5.85M	5.96M	7.50M	5.50M	6.07M
EPS Basic	0.86	0.50	-0.75	0.66	0.45	0.87	-1.31	-0.31	0.63
EPS Diluted	0.84	0.49	-0.75	0.65	0.45	0.85	-1.31	-0.31	0.63
Weighted Average Basic Shares	5.66M	5.66M	5.54M	5.53M	5.51M	5.46M	5.43M	5.43M	5.41M
Weighted Average Diluted Shares	5.76M	5.76M	5.54M	5.57M	5.54M	5.55M	5.43M	5.43M	5.47M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	03/31/2026	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021	03/31/2020	03/31/2019
Revenue	249.13M	240.98M	216.19M	219.08M	184.34M	133.94M	117.69M	103.14M
Cost of Goods Sold	90.86M	90.11M	82.94M	85.39M	75.25M	46.92M	52.33M	42.22M
Gross Profit	158.27M	150.87M	133.25M	133.69M	109.09M	87.01M	65.36M	60.92M
Gross Profit Margin	63.5%	62.6%	61.6%	61.0%	59.2%	65.0%	55.5%	59.1%
Total Operating Expenses	139.76M	134.53M	405.32M	130.37M	104.39M	74.66M	57.44M	43.06M
Research & Development	20.31M	19.52M	19.30M	20.49M	15.77M	10.39M	6.36M	3.51M
Selling, General & Administrative	119.45M	115.02M	111.49M	109.88M	88.62M	64.27M	51.08M	39.55M
Operating Income (EBIT)	18.51M	16.34M	-272.07M	3.32M	4.70M	12.36M	7.92M	9.78M
Operating Margin	7.4%	6.8%	-125.9%	1.5%	2.6%	9.2%	6.7%	9.5%
Income Before Tax (EBT)	12.01M	5.96M	-275.65M	-389K	3.57M	2.30M	3.86M	8.62M
Interest Income	N/A	N/A	N/A	N/A	N/A	107K	960K	1.72M
Interest Expense	10.69M	11.86M	5.70M	4.77M	3.88M	8.02M	5.50M	N/A
Other Income/Expense	-6.50M	-10.38M	-3.57M	-3.71M	-1.13M	-10.05M	-4.06M	-1.16M
Net Income	6.71M	-1.97M	-254.25M	930K	1.87M	3.27M	1.78M	7.48M
Income Tax Expense	5.30M	7.93M	-21.40M	-1.32M	1.70M	-971K	2.08M	1.14M
Net Profit Margin	2.7%	-0.8%	-117.6%	0.4%	1.0%	2.4%	1.5%	7.3%
EBITDA	41.78M	40.86M	-240.50M	36.45M	29.77M	30.02M	20.91M	19.25M
EBITDA Margin	16.8%	17.0%	-111.2%	16.6%	16.1%	22.4%	17.8%	18.7%
Depreciation & Amortization	23.27M	24.53M	31.57M	33.13M	25.07M	17.66M	12.99M	9.47M
EPS Basic	1.22	-0.36	-47.20	0.17	0.36	0.66	0.32	1.95
EPS Diluted	1.21	-0.36	-47.20	0.17	0.35	0.64	0.31	1.86
Weighted Average Basic Shares	5.51M	5.43M	5.39M	5.32M	5.21M	4.97M	4.20M	3.84M
Weighted Average Diluted Shares	5.57M	5.43M	5.39M	5.36M	5.33M	5.12M	4.37M	4.03M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.